---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-002466"
form_type: "8-K"
ticker: "FHTX"
cik: "0001822462"
company_name: "Foghorn Therapeutics Inc."
filed_at: "2025-01-24T23:59:59+00:00"
generated_at: "2026-05-27T11:33:33.422012+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Foghorn Therapeutics receives Nasdaq non-compliance notice over audit committee composition

## Summary
- Nasdaq notified Foghorn on Jan 23, 2025 that its audit committee has only two members, violating Listing Rule 5605.
- Vacancy follows resignation of director Adam M. Koppel from board and audit committee effective Dec 29, 2024.
- Cure period runs until earlier of next annual meeting or Dec 29, 2025; if meeting before June 27, 2025, then by June 27, 2025.
- Board intends to appoint a new independent director to fill the audit committee vacancy within the cure period.

## SEC filing metadata
- accession: 0001628280-25-002466
- form_type: 8-K
- ticker: FHTX
- cik: 0001822462
- company_name: Foghorn Therapeutics Inc.
- filed_at: 2025-01-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822462/000162828025002466/0001628280-25-002466-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822462/000162828025002466/fhtx-20250123.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-002466
- JSON: https://secwatch.observer/filing/0001628280-25-002466.json
- Plain text: https://secwatch.observer/filing/0001628280-25-002466.txt

## Source-grounded claims
- claim_id: fae198e41a88bc8bd9db191c9b5c338a769a06e1
  claim: Foghorn Therapeutics Inc. received a nasdaq deficiency notice notice regarding audit committee.
  evidence_excerpt: January 23, 2025, Foghorn Therapeutics Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Stock Market LLC (the “Nasdaq”) notifying the Company that it no longer complies with Nasdaq’s audit committee
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822462/000162828025002466/0001628280-25-002466-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.